0.25Open0.25Pre Close0 Volume4.15K Open Interest1.00Strike Price0.00Turnover62.18%IV3.31%PremiumSep 20, 2024Expiry Date0.21Intrinsic Value100Multiplier26DDays to Expiry0.04Extrinsic Value100Contract SizeAmericanOptions Type0.8925Delta0.9093Gamma5.38Leverage Ratio-0.0008Theta0.0006Rho4.80Eff Leverage0.0006Vega
Adaptimmune Therapeutics Stock Discussion
😩. I wish I had more capital. This is about to run hard.
Turnaround proxy after FDA approval.
The treatment or cure of cancer, will be a huge business.
$Adaptimmune Therapeutics (ADAP.US)$
No comment yet